X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (155) 155
soluble interleukin-2-receptor (135) 135
index medicus (114) 114
female (88) 88
male (86) 86
middle aged (73) 73
adult (68) 68
hematology (54) 54
oncology (52) 52
immunology (49) 49
aged (44) 44
cytokines (38) 38
prognosis (32) 32
expression (27) 27
transplantation (26) 26
serum-levels (25) 25
adolescent (24) 24
inflammation (23) 23
receptors, interleukin-2 - blood (23) 23
analysis (22) 22
biomarkers - blood (22) 22
cancer (22) 22
aged, 80 and over (21) 21
t cells (21) 21
treatment outcome (20) 20
disease (19) 19
soluble interleukin-2 receptor (19) 19
animals (18) 18
bone-marrow-transplantation (18) 18
cells (18) 18
child (18) 18
diagnosis (18) 18
lymphocytes (18) 18
biomarkers (17) 17
lymphomas (17) 17
regulatory t-cells (17) 17
stem-cell transplantation (17) 17
biomarkers, tumor - blood (16) 16
c-reactive protein (16) 16
medicine & public health (16) 16
survival (16) 16
abridged index medicus (15) 15
non-hodgkins-lymphoma (15) 15
tumor-necrosis-factor (15) 15
case-control studies (14) 14
interleukin-2 receptor alpha subunit - metabolism (14) 14
young adult (14) 14
article (13) 13
chemotherapy (13) 13
child, preschool (13) 13
il-2 receptor (13) 13
pediatrics (13) 13
receptor (13) 13
serum (13) 13
stem cells (13) 13
versus-host-disease (13) 13
enzyme-linked immunosorbent assay (12) 12
graft vs host disease - diagnosis (12) 12
immunosuppressive agents - therapeutic use (12) 12
interleukin 2 (12) 12
interleukins (12) 12
leukemia (12) 12
lymphoma (12) 12
necrosis-factor-alpha (12) 12
predictive value of tests (12) 12
transplantation, homologous (12) 12
activation (11) 11
acute disease (11) 11
blood (11) 11
children (11) 11
follow-up studies (11) 11
hematopoietic stem cells (11) 11
lymphocytes t (11) 11
macrophage activation syndrome (11) 11
recurrence (11) 11
serum-soluble interleukin-2-receptor (11) 11
care and treatment (10) 10
cell biology (10) 10
hematopoietic stem cell transplantation (10) 10
immunotherapy (10) 10
interleukin-2-receptor (10) 10
mice (10) 10
prospective studies (10) 10
receptors, interleukin-2 - metabolism (10) 10
research (10) 10
retrospective studies (10) 10
rheumatoid-arthritis (10) 10
t-cells (10) 10
t-lymphocytes - immunology (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
autoimmunity (9) 9
b-cell lymphoma (9) 9
cd25 (9) 9
dermatology (9) 9
flow cytometry (9) 9
infant (9) 9
interferon-gamma (9) 9
interleukin (9) 9
interleukin-2 (9) 9
interleukin-2 receptor alpha subunit - genetics (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 10/2017, Volume 179, Issue 1, pp. 20 - 35
Summary CD25 (also termed IL2RA) forms one component of the high‐affinity heterotrimeric interleukin 2 (IL2) receptor on activated T cells. Its affinity for... 
regulatory T cells | interleukin‐2 receptor | CD25 | anti‐CD25 targeted therapy | CD25‐expressing malignancies | CD25-expressing malignancies | interleukin-2 receptor | anti-CD25 targeted therapy | MONOCLONAL-ANTIBODY TREATMENT | SERUM-SOLUBLE INTERLEUKIN-2-RECEPTOR | FOLLICULAR LYMPHOMA | REGULATORY T-CELLS | IMMUNOTOXIN RFT5-SMPT-DGA | INTERLEUKIN-2-RECEPTOR ALPHA-CHAIN | RETROSPECTIVE ANALYSIS | HEMATOLOGY | C-RECEPTOR POLYMORPHISMS | PHASE-I | HEMATOLOGIC MALIGNANCIES | Interleukin-2 - metabolism | Neoplasms - metabolism | Immunomodulation - drug effects | T-Lymphocytes, Regulatory - metabolism | Interleukin-2 Receptor alpha Subunit - antagonists & inhibitors | Antibodies, Monoclonal - pharmacology | Humans | Receptors, Interleukin-2 - metabolism | Antibodies, Monoclonal - therapeutic use | Molecular Targeted Therapy | Neoplasms - drug therapy | T-Lymphocytes, Regulatory - immunology | Gene Expression Regulation - drug effects | T-Lymphocytes, Regulatory - drug effects | Interleukin-2 Receptor alpha Subunit - genetics | Interleukin-2 Receptor alpha Subunit - metabolism | Neoplasms - genetics | Signal Transduction - drug effects | Neoplasms - immunology | Immunologic Factors - pharmacology | Immunologic Factors - therapeutic use | Interleukin-2 Receptor alpha Subunit - immunology | Biological products | T cells | Stem cells | Cancer | Medical research | Interleukin 2 receptors | Hematology | Immunomodulation | Interleukin | Clinical trials | Lymphocytes T | Modulators | Immunotoxins | Signal transduction | Signaling | Interleukin 2 | Lymphocytes | CD25 antigen | Affinity | Tumors | Immune system | Index Medicus
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 02/2019, Volume 34, Issue 2, pp. 234 - 242
Abstract Background Early detection of renal involvement in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is of major clinical... 
WEGENERS-GRANULOMATOSIS | ANTIBODIES | INTERLEUKIN-2-RECEPTOR | soluble CD163 | soluble CD25 | MARKERS | renal dysfunction | DISEASE-ACTIVITY | TRANSPLANTATION | MAINTENANCE | ANCA vasculitis | T-CELL-ACTIVATION | NEPHRITIS | UROLOGY & NEPHROLOGY | glomerulonephritis
Journal Article
Journal Article
NATURE REVIEWS RHEUMATOLOGY, ISSN 1759-4790, 06/2016, Volume 12, Issue 6, pp. 318 - U19
Journal Article
Veterinary Immunology and Immunopathology, ISSN 0165-2427, 09/2019, Volume 215, p. 109904
During immune activation, CD25 is expressed by T cells, and its soluble form (sCD25) is released into the extracellular matrix and the bloodstream. In humans,... 
p55 | Interleukin 2 receptor alpha | Soluble CD25 | Radioimmunoassay | tac | Canine | GAMMA | ACTIVATION | IMMUNOLOGY | RECEPTOR-ALPHA | CHILDREN | INTERLEUKIN-2-RECEPTOR ALPHA | REFERENCE INTERVALS | GROWTH | VETERINARY SCIENCES | EXPRESSION | T-LYMPHOCYTES
Journal Article
LEUKEMIA & LYMPHOMA, ISSN 1042-8194, 01/2019, Volume 60, Issue 1, pp. 19 - 28
Hemophagocytic lymphohistiocytosis (HLH), a rare but life-threatening condition characterized by uncontrolled inflammation, is increasingly recognized in... 
DIAGNOSIS | HLH-94 IMMUNOCHEMOTHERAPY | PROGNOSTIC-FACTORS | HLH | malignancy-associated HLH | CLINICAL CHARACTERISTICS | secondary HLH | SOLUBLE INTERLEUKIN-2-RECEPTOR | ONCOLOGY | MACROPHAGE ACTIVATION SYNDROME | DISEASE | SALVAGE THERAPY | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY
Journal Article